Carla Demuro MS

Carla DeMuro, MS, is Head of Patient-Centered Outcomes Assessment in RTI-HS. Ms. DeMuro has extensive experience in the rigorous development and validation of patient-reported outcome measures for use in clinical trials, as well as large-scale epidemiologic and population-based studies. She joined RTI-HS after 15 years of working in the pharmaceutical industry and brings her experience with and understanding of the FDA Guidance for Patient-Reported Measures. Ms. DeMuro has worked to developed measures across a wide span of therapeutic areas, including but not limited to respiratory illness (asthma, chronic obstructive pulmonary disease, allergic rhinitis, influenza), oncology (non–small cell and small cell lung cancer), Alzheimer's disease, infectious disease (including sexually transmitted disease), sleep disorders, hair loss (male and female), menopausal symptoms, cognition, acne, benign prostatic hyperplasia, osteoarthritis, rheumatoid arthritis, diabetes, and migraine. Measures have included multiple types of patient-reported outcomes, including quality of life, treatment satisfaction, symptom severity, daily event logs, patient diaries, utility measures, and other patient-reported outcomes. She has specialized in both the qualitative and quantitative aspects of instrument design and has worked toward creating a clear path from measure development to interpretation.